A Comprehensive Cancer Gene Test Gets the Go-Ahead

Main|Search|PHGKB




Last Posted: Dec 07, 2017

---

• A Comprehensive Cancer Gene Test Gets the Go-Ahead  
  K Sheikh, Genome Magazine, Dec 4, 2017
• Applications of pharmacogenomics in regulatory science: a product life cycle review.  
  Tan-Koi W C et al. The pharmacogenomics journal 2017 Dec
• Ethical considerations in gene therapy.  
  Levin Alex V et al. Ophthalmic genetics 2016 37(3) 249-51
• FDA announces approval, CMS proposes coverage of first breakthrough-designated test to detect extensive number of cancer biomarkers,  
  FDA News Release, November 30, 2017
• Huntington's case raises questions about passing gene test results to relatives.  
  Dyer Clare et al. BMJ (Clinical research ed.) 2017 357j2433
• Insurance for broad genomic tests in oncology.  
  Eisenberg Rebecca et al. Science (New York, N.Y.) 2017 358(6367) 1133-1134
• One small edit for humans, one giant edit for humankind? Points and questions to consider for a responsible way forward for gene editing in humans. 
  Howard Heidi C et al. European journal of human genetics : EJHG 2017 Nov
• Direct to consumer genetic testing-law and policy concerns in Ireland.  
  de Paor Aisling et al. Irish journal of medical science 2017 Nov
• FDA treads carefully on molecular diagnostics,  
  by Josh Baxt, MedCity News, November 21, 2017
• First-In-Human Phase 1 CRISPR Gene Editing Cancer Trials: Are We Ready?  
  Baylis Francoise et al. Current gene therapy 2017 Nov
• For Greater Diversity,  
  Genome Web, November 27, 2017
• Improved ethical guidance for the return of results from psychiatric genomics research.  
  Lázaro-Muñoz G et al. Molecular psychiatry 2017 Nov
• Next-generation sequencing in clinical practice: from the patients' preferences to the informed consent process.  
  Pélissier A et al. Public health 2016 138157-9
• Physicians' duty to recontact and update genetic advice.  
  Stevens Yvonne A et al. Personalized medicine 2017 14(4) 367-374
• Psychosocial issues of a population approach to high genetic risk identification: Behavioural, emotional and informed choice issues.  
  French David P et al. Breast (Edinburgh, Scotland) 2017 Nov 37148-153
• Reconciling ethical and economic conceptions of value in health policy using the capabilities approach: A qualitative investigation of Non-Invasive Prenatal Testing.  
  Kibel Mia et al. Social science & medicine (1982) 2017 Nov 19597-104

more